Nutri Pharmaceuticals Research Inc
Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its "oil to powder' products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and org… Read more
Nutri Pharmaceuticals Research Inc (NRPR) - Net Assets
Latest net assets as of December 2003: $238.35K USD
Based on the latest financial reports, Nutri Pharmaceuticals Research Inc (NRPR) has net assets worth $238.35K USD as of December 2003.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($675.99K) and total liabilities ($437.63K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $238.35K |
| % of Total Assets | 35.26% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Nutri Pharmaceuticals Research Inc - Net Assets Trend (2003–2003)
This chart illustrates how Nutri Pharmaceuticals Research Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nutri Pharmaceuticals Research Inc (2003–2003)
The table below shows the annual net assets of Nutri Pharmaceuticals Research Inc from 2003 to 2003.
| Year | Net Assets | Change |
|---|---|---|
| 2003-12-31 | $238.35K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nutri Pharmaceuticals Research Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Current Equity Component Breakdown (December 2003)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $33.92K | 14.23% |
| Other Components | $392.66K | 164.74% |
| Total Equity | $238.35K | 100.00% |
Nutri Pharmaceuticals Research Inc Competitors by Market Cap
The table below lists competitors of Nutri Pharmaceuticals Research Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHINA OIL AND GAS - Dusseldorf Stock Exchang
DU:GPI1
|
$197.15 |
|
CHAODA MODERN AGRI
BE:CHA
|
$197.64 |
|
Minoan Group
LSE:MIN
|
$197.85 |
|
Sinar Terang Mandiri PT Tbk
JK:MINE
|
$197.92 |
|
Egyptian Real Estate Group
EGX:AREH
|
$196.80 |
|
Lauritz.com A/S
ST:LAUR
|
$196.68 |
|
Ichor Coal N.V
HM:IO0
|
$196.45 |
|
NEM INSURANCE PLC
XNSA:NEM
|
$195.82 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nutri Pharmaceuticals Research Inc's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Nutri Pharmaceuticals Research Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $0.00 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nutri Pharmaceuticals Research Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -65.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -124.94%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 2.84x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -65.99% | -124.94% | 0.19x | 2.84x | $-181.12K |
Industry Comparison
This section compares Nutri Pharmaceuticals Research Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nutri Pharmaceuticals Research Inc (NRPR) | $238.35K | -65.99% | 1.84x | $197.02 |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |